Model #	Disease Area	Disease Feature	Category	Type	Application	Application Sub-Category	Biological Endpoints	Throughput	Relevance	Status	Year	First Author Name	DOI	
1	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device development	Bioprosthetic heart valves	Medium / Low (Lab scale)	Supportive	Under development 	2019	Abbasi M.	10.1007/s10439-018-02129-5	
2	Myocardia Ischemia	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Stent failure	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Adjedj J.	10.1002/ccd.27718	
3	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Subclavian steal syndrome	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Agujetas R.	10.1007/s10237-017-0898-2	
4	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Heart valve-related disease	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Alavi S.H.	10.1007/s10439-016-1778-0	
5	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease etiology and risk factors	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2017	Albanese I.	10.1161/ATVBAHA.116.308394	
6	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Prosthesis effectiveness evaluation	TMVR outcome prediction	Medium / Low (Lab scale)	Predictive	Optimisation	2019	Alharbi Y.	10.1016/j.jcct.2019.11.016	
7	Heart Failure 	NA	in silico	FEM	Disease therapy development	Prediction of device effects	LVAD Cannula effect and thrombus evaluation	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Aliseda A.	10.1097/MAT.0000000000000443	
8	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prosthesis effectiveness evaluation	Aortic bileaflet mechanical heart valve	Not relevant (e.g. in silico)	Direct	Standardised 	2014	Annerel S.	10.1016/j.medengphy.2014.05.004	
9	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Treatment of Tetralogy of Fallot	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Anwar S.	10.1007/s11936-018-0594-2	
10	Cardiovascular Abnormalities including CCD 	NA	ex vivo	NA	Disease mechanism (exp/theor)	Diagnosis of diseases	Congenital heart disease	High (Automated)	Predictive	Optimisation	2013	Aoki Y. 	10.1016/j.ajhg.2013.05.021	
11	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Shunt banding	Medium / Low (Lab scale)	Supportive	Under development 	2016	Atlin C.R.	10.1016/j.jtcvs.2016.07.081	
12	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Rupture of ballon-expandable stent	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Auricchio F.	10.1016/j.ijfatigue.2015.02.002	
13	Occlusive Disease 	Veins	in silico	FEM	Disease therapy development	Disease etiology and risk factors	Inferior vena cava filters to prevent pulmonary embolism	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Aycock K.I.	10.1007/s10439-016-1663-x	
14	Occlusive Disease 	Veins	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Inferior vena cava filters to prevent pulmonary embolism	High (Automated)	Supportive	Standardised 	2017	Aycock K.I.	10.1007/s10237-016-0857-3	
15	Occlusive Disease 	Veins	in silico	FEM	Disease therapy development	Prediction of device effects	Blood clot of inferior vena cava	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Aycock K.I.	10.1115/1.4027612	
16	Heart Valve Diseases 	Mitral Valve	in vitro with cells	3D culture	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve remodeling evaluation	Medium / Low (Lab scale)	Predictive	Under development 	2017	Ayoub S.	10.1098/rsif.2017.0580	
17	Cardiovascular Abnormalities including CCD 	NA	ex vivo	NA	Disease mechanism (exp/theor)	Diagnosis of diseases	Tetralogy of Fallot	High (Automated)	Predictive	Under development 	2014	Baban A.  	10.1002/ajmg.a.36783	
18	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Transcatheter mitral valve replacement	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Bagur R.	10.1016/j.jcin.2017.10.049	
19	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Diagnosis of disease	Treatment strategies evaluation	Atrial flutter / atrial fibrillation	High (Automated)	Direct	Optimisation	2014	Bahnson T.D.	10.1111/jce.12514	
20	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease mechanism and progression	Understanting of the genetic mutation effects on ventricular tachycardia	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Bai J.	10.1038/srep31262	
21	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Bypass grafts configuration in coronary artery disease	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Ballarin F.	10.1007/s10237-017-0893-7	
22	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Treatment strategies evaluation	Myocardium modeling	Medium / Low (Lab scale)	Supportive	Under development 	2014	Bane O.	10.1016/j.mri.2013.10.014	
23	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Valve failure	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Bapat V.	10.4244/EIJV11I11A251	
24	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve regurgitation	Not relevant (e.g. in silico)	Supportive	Under validation	2017	Bavo A.M.	10.1016/j.jbiomech.2016.11.039	
25	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Gene therapy of hypertrophic cardiomyopathy effectiveness evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Ben Jehuda R.	10.1016/j.hrthm.2017.09.024	
26	Heart Failure 	NA	in vitro without cells	NA	Disease therapy development	Prediction of device effects	LVAD Cannula effect	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Benk C.	10.1093/ejcts/ezt095	
27	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aortic root hemodynamics	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Berdajs D.	10.1093/ejcts/ezv295	
28	Aneurysm	Aorta	ex vivo	NA	Disease mechanism (exp/theor)	Diagnosis of diseases	Hypertension complications	Medium / Low (Lab scale)	Predictive	Under development 	2017	Bersi M.R.	10.1098/rsif.2017.0327	
29	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Quantitative analysis of action potential parameters	Medium / Low (Lab scale)	Unknown	Optimisation	2013	Bett G.C.L.	10.1016/j.hrthm.2013.09.061	
30	Heart Valve Diseases 	Pulmonary Valve	in vitro without cells	NA	Diagnosis of disease	Treatment strategies evaluation	RVOT obstuction	Medium / Low (Lab scale)	Supportive	Under validation	2013	Biglino G.	10.1186/1532-429X-15-2	
31	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Hypertrophic cardiomyopathy iPSC study	Medium / Low (Lab scale)	Supportive	Under development 	2015	Birket M.J.	10.1016/j.celrep.2015.09.025	
32	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Diagnosis of disease	Surgical and/or interventional planning	Subclavian stenoses	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Blanco P.J.	10.1016/j.jbiomech.2016.03.044	
33	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Aneurysm hemodynamics	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Blankena R.	10.3174/ajnr.A4734	
34	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Proarrhythmia prediction; in silico modeling prediction of proarrhythmic risk	Medium / Low (Lab scale)	Supportive	Under validation	2017	Blinova K.	10.1093/toxsci/kfw200	
35	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	MV geometry imaging reconstruction	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Bloodworth C.H.	10.1007/s10439-016-1734-z	
36	Aneurysm	Aorta	in silico	FEM	Disease mechanism (exp/theor)	Diagnosis of diseases	Aneurysm hemodynamics	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Boccadifuoco A. 	10.1007/s13239-018-00387-x	
37	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease effects on specific organs	Bicuspid aortic valve	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Bonomi D.  	10.1007/s10237-015-0679-8	
38	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2015	Bouchareb R. 	10.1161/CIRCULATIONAHA.115.016757	
39	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Prosthesis development	TMVR design	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Bozkurt S.	10.1007/s10439-017-1828-2	
40	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Arteriovenous fistula	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Browne L.D.	10.1007/s10439-015-1295-6	
41	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease therapy development	Device development	Regeneration of cardiovascular tissues	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Brugmans M.M.C.P.	10.1089/ten.tea.2015.0203	
42	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Paravalvular leak 	Not relevant (e.g. in silico)	Supportive	Optimisation	2016	Burriesci G.	10.1016/j.ijcard.2015.11.106	
43	Heart Valve Diseases 	Pulmonary Valve	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Calcific obstraction of RVOT	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Caimi A.	10.1016/j.jbiomech.2018.08.006	
44	Heart Valve Diseases 	Aortic Valve	in vitro without cells	NA	Disease therapy development	Disease effects on specific organs	Transcatheter aortic valve implantation	Not relevant (e.g. in silico)	Supportive	Optimisation	2016	Calderan J.	10.1111/aor.12589	
45	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Bicuspid aortic valve	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Cao K.	10.1016/j.jbiomech.2016.11.024	
46	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Congenital heart disease	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Capelli C. 	10.1098/rsfs.2017.0021	
47	Aneurysm	Aorta	in silico	FEM	Disease mechanism (exp/theor)	Diagnosis of diseases	Aneurysm hemodynamics	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Capellini K. 	10.1115/1.4040940	
48	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Vascular access dysfunction	Not relevant (e.g. in silico)	Supportive	Under validation	2013	Caroli A.	10.1038/ki.2013.188	
49	Heart Failure 	NA	in silico	FEM	Disease therapy development	Prediction of device effects	LVAD Cannula effect	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Caruso M.V.	10.1002/cnm.2700	
50	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Myocardial infarction	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Castells-Sala C.	10.1002/jbm.a.35482	
51	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Disease therapy development	Prediction of post-intervention outcomes	Abdominal vascular graft infection	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Charlton-Ouw K.M.	10.1016/j.jvs.2014.03.241	
52	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Monitoring of changes in cardiac performance under various conditions	Medium / Low (Lab scale)	Unknown	Optimisation	2014	Chen A.	10.1016/j.biomaterials.2013.10.007	
53	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Thrombosis and restenosis	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Chen H.	10.1039/C6TB01811D	
54	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Predictive	Under validation	2015	Chen J.	10.1161/ATVBAHA.114.305095	
55	Cardiovascular Surgical and interventional Procedures	Reperfusion	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease effects on specific organs	Hypoxia/reoxygenation injury	Medium / Low (Lab scale)	Predictive	Optimisation	2018	Chen L.-J.	10.1097/SHK.0000000000001008	
56	Heart Valve Diseases 	Mitral Valve	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	MicroRNA on mitral valve prolapse	Medium / Low (Lab scale)	Predictive	Under validation	2016	Chen M.	10.3390/ijms17050753	
57	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease mechanism (exp/theor)	Diagnosis of diseases	Aortic valve dynamics	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Chen Y. & Luo H.	10.1016/j.jfluidstructs.2018.04.009	
58	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Tricuspid atresia	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Chen Y.-T.	10.1097/MD.0000000000009510	
59	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Aortic valve replacement	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Cheng Z.	10.1007/s10439-015-1453-x	
60	Heart Failure 	NA	in silico	FEM	Disease therapy development	Prediction of device effects	Thrombosis risk of VAD	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Chivukula V.K.	10.1161/CIRCHEARTFAILURE.117.004325	
61	Aneurysm	Cerebral	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Aneurysm rupture	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Chivukula V.K. 	10.1016/j.jocn.2018.10.103	
62	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Coronary plaques	High (Automated)	Supportive	Optimisation	2015	Choi G.	10.1016/j.jcmg.2015.04.024	
63	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device development	Atrial fibrillation	Not relevant (e.g. in silico)	Supportive	Optimisation	2015	Choi H.W.	10.1016/j.jbiomech.2015.05.006	
64	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Effect of plasma endothelial microparticles on valve regurgitation and stenosis	Medium / Low (Lab scale)	Supportive	Under validation	2013	Ci H.-B.	10.1152/ajpendo.00016.2013	
65	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Endothelial function in carotid artery	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Cibis M.	10.1016/j.jbiomech.2016.02.004	
66	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2017	Cirka H.A.	10.1039/c6lc01226d	
67	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prosthesis effectiveness evaluation	Aortic calcification	Not relevant (e.g. in silico)	Direct	Standardised 	2013	Claiborne T.E.	10.1115/1.4023235	
68	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Diagnosis of disease	Treatment strategies evaluation	Left atrial appendage closure	Medium / Low (Lab scale)	Predictive	Optimisation	2017	Coisne A.	10.1016/j.hrthm.2017.01.042	
69	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Failure of bioprosthetic heart valves	Medium / Low (Lab scale)	Supportive	Under development 	2016	Condemi F.	10.1016/j.echo.2015.11.002	
70	Heart Valve Diseases 	Mitral Valve	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve remodeling evaluation	Medium / Low (Lab scale)	Predictive	Under development 	2016	Connell P.S.	10.1007/s10439-015-1398-0	
71	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Single ventricle physiology	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Conover T. 	10.1016/j.jtcvs.2017.09.046	
72	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Effect of arterial predilation before stenting	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Conway C.	10.1007/s10439-017-1851-3	
73	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Stent resistence in right ventricular outflow tract	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Cools B.	10.1002/ccd.27320	
74	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Evaluation of changes in AV nodal properties during atrial fibrillation	Not relevant (e.g. in silico)	Supportive	Under validation	2014	Corino V.D.A.	10.1093/europace/euu246	
75	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Single ventricle	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Corsini C.  	10.1080/10255842.2012.758254	
76	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Device development	Aneurysm endovascular repair	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Costache V.S.	10.1177/1526602818808049	
77	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Device effectiveness evaluation	Epicardial pacing	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Crowe M.E.	10.1097/SIH.0b013e31826ec3e1	
78	Heart Failure 	NA	in vitro without cells	NA	Diagnosis of disease	Prediction of post-intervention outcomes	LVAD fluidodynamic evaluation	Medium / Low (Lab scale)	Predictive	Under development 	2014	Cuenca-Navalon E.	10.5301/ijao.5000301	
79	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Prosthesis development	Mitral valve scaffold realisation feasibility	Not relevant (e.g. in silico)	Supportive	Under development 	2018	D'Amore A.	10.1016/j.biomaterials.2017.10.011	
80	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prosthesis effectiveness evaluation	Bicuspid aortic valve	Not relevant (e.g. in silico)	Direct	Standardised 	2016	Dabiri Y.	10.1007/s13239-016-0279-5	
81	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Disease therapy development	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Davari S.A.	10.1002/jbio.201600288	
82	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2013	De Bock S.	10.1016/j.jbiomech.2013.07.010	
83	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Prosthesis development	Heart valve fluid dynamic evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2015	De Gaetano F.	10.5301/ijao.5000452	
84	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Arteriovenous fistula	Not relevant (e.g. in silico)	Supportive	Under development 	2018	de Villiers A.M.	10.1007/s10237-017-0973-8	
85	Heart Valve Diseases 	Mitral Valve	in vitro with cells	3D culture	Disease therapy development	Prosthesis development	Mitral valve scaffold realisation feasibility	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Deborde C.	10.1089/ten.tea.2016.0032	
86	Aneurysm	Aorta	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Aneurysm hemodynamics	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Deplano V.	10.1007/s00348-016-2263-0	
87	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aneurysm rupture	High (Automated)	Supportive	Standardised 	2018	Detmer F.J.	10.1007/s00701-018-3712-8	
88	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Atherosclerosis	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Díaz-Zuccarini V.	10.1049/htl.2013.0040	
89	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Rupture risk of plaque	Medium / Low (Lab scale)	Supportive	Under development 	2013	Doherty J.R.	10.1016/j.jbiomech.2012.10.006	
90	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Artificial blood vessel	Medium / Low (Lab scale)	Supportive	Optimisation	2014	Dolati F.	10.1088/0957-4484/25/14/145101	
91	Occlusive Disease 	Carotid	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Carotid restenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Domanin M.	10.1016/j.jvs.2017.08.094	
92	Occlusive Disease 	Carotid	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Carotid restenosis	Medium / Low (Lab scale)	Supportive	Under development 	2019	Domanin M.	10.1007/s10439-019-02201-8	
93	Occlusive Disease 	Peripheral vessel	in silico	FEM	Disease therapy development	Prediction of device effects	Femoral artery stenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Dordoni E.	10.1016/j.medengphy.2014.03.006	
94	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve remodeling evaluation	Medium / Low (Lab scale)	Predictive	Under validation	2018	Driesbaugh K.H.	10.1016/j.yjmcc.2017.12.014	
95	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Treatment strategies evaluation	Understanding of the molecular basis of antiarrhythmics; assessment of arrhythmia response to drugs	Medium / Low (Lab scale)	Predictive	Optimisation	2014	Du C.	10.1016/j.yjmcc.2014.05.013	
96	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Diagnosis of disease	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2013	Duan B.	10.1016/j.actbio.2013.04.050	
97	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Disease mechanism and progression	Leaflets stenosis and calcification	Medium / Low (Lab scale)	Direct	Under validation	2014	Dubé J.	10.1016/j.actbio.2014.04.033	
98	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Aortic thrombosis	Medium / Low (Lab scale)	Predictive	Optimisation	2016	Ducci A.	10.1016/j.jbiomech.2016.10.050	
99	Aneurysm	Aorta	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Aneurysm growth	High (Automated)	Predictive	Under development 	2014	Duellman T.	10.1016/j.jvs.2014.03.274	
100	Aneurysm	Aorta	in silico	FEM	Diagnosis of disease	Prediction of device effects	Aneurysm endovascular repair	Not relevant (e.g. in silico)	Predictive	Under validation	2013	Dumenil A.	10.1109/TBME.2012.2235440	
101	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease etiology and risk factors 	Effect of DCHS1 on mitral valve	Medium / Low (Lab scale)	Predictive	Under validation	2015	Durst R.	10.1038/nature14670	
102	Myocardia Ischemia	NA	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease mechanism and progression	Acute myocardial infarction	Medium / Low (Lab scale)	Supportive	Under validation	2017	Dutta S.	10.1016/j.pbiomolbio.2017.02.007	
103	Myocardia Ischemia	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Bifurcation stenting	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Džavík V. & Colombo A.	10.1016/j.jcin.2013.07.013	
104	Occlusive Disease 	Peripheral vessel	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Diagnosis of diseases	Arterial wall stiffening	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Ebrahimi Nejad S.	10.1007/s10237-016-0836-8	
105	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Mitral annular calcification	Medium / Low (Lab scale)	Supportive	Optimisation	2018	El Sabbagh A.	10.1002/ccd.27488	
106	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease therapy development	Device development	Pathophysiology of the myocardium	Medium / Low (Lab scale)	Supportive	Optimisation	2017	Ellis B.W.	10.1063/1.4978468	
107	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Mitral valve regurgitation	Not relevant (e.g. in silico)	Supportive	Optimisation	2019	Engelhardt S.	10.1093/icvts/ivz008	
108	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Diagnosis of disease	Surgical and/or interventional planning	Abdominal aortic aneurysm	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Erhart P.	10.1583/14-4695.1	
109	Aneurysm	Aorta	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Aneurysm rupture	Medium / Low (Lab scale)	Predictive	Standardised 	2015	Erhart P.	10.1016/j.ejvs.2014.11.010	
110	Aneurysm	Aorta	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aneurysm rupture	Medium / Low (Lab scale)	Predictive	Standardised 	2016	Erhart P.	10.1177/1526602815612196	
111	Heart Valve Diseases 	Mitral Valve	in vitro with cells	3D culture	Disease therapy development	Prosthesis development	Mitral valve scaffold realisation feasibility	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Eslami M.	10.1177/0885328214530589	
112	Myocardia Ischemia	NA	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Coronary stent fracture	Medium / Low (Lab scale)	Predictive	Under validation	2016	Everett K.D.	10.1007/s10439-015-1476-3	
113	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Failed mitral surgical bioprostheses	Medium / Low (Lab scale)	Supportive	Under validation	2016	Evin M.	10.1016/j.jtcvs.2015.11.039	
114	Cardiovascular Abnormalities including CCD 	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Double outlet right ventricle	Not relevant (e.g. in silico)	Supportive	Under validation	2016	Farooqi K.M.	10.1177/2150135115610285	
115	Aneurysm	Aorta	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aneurysm rupture	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Farzaneh S.	10.1007/s10237-018-1073-0	
116	Cardiomyopathies 	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Cardiac patches realisation feasibility	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Feiner R.	10.1016/j.jconrel.2018.05.023	
117	Cardiovascular Surgical and interventional Procedures	Reperfusion	in vitro with cells	2D culture 	Disease therapy development	General disease effects on the body	Hypoxia/reoxygenation injury	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Femminò S.	10.3390/polym10020211	
118	Aneurysm	Aorta	in vitro without cells	NA	Disease therapy development	Prediction of device effects	Grafts for aneurysm and dissections	Not relevant (e.g. in silico)	Supportive	Under validation	2019	Ferrari G.	10.1016/j.jbiomech.2019.01.053	
119	Myocardia Ischemia	NA	in vitro without cells	NA	Disease therapy development	Prediction of post-intervention outcomes	Coronary bifurcation stenting	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Finet G.	10.1016/j.jcin.2015.05.016	
120	Cardiomyopathies 	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Human iPSC cardiomyocytes production	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Fischer B.	10.1016/j.scr.2018.08.015	
121	Myocardia Ischemia	NA	in vitro without cells	NA	Diagnosis of disease	Diagnosis of diseases	Coronary artery fistulae	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Forte M.N.V.	10.4244/EIJ-D-16_00897	
122	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Intracranial aneurysms 	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Frölich A.M.J.	10.3174/ajnr.A4486	
123	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	TMVR outcome prediction	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Gaidulis G.	10.15388/NA.2019.4.1	
124	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Aortic arch rupture risk	Not relevant (e.g. in silico)	Supportive	Under development 	2014	García-Herrera C.M. & Celentano D.J.	10.1007/s10237-013-0471-6	
125	Myocardia Ischemia	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Coronary stent therapy	Medium / Low (Lab scale)	Supportive	Under validation	2014	Gassenmaier T.	10.1007/s00330-014-3323-6	
126	Aneurysm	Aorta	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aneurysm rupture	High (Automated)	Predictive	Under validation	2014	Gasser T.C.	10.1016/j.ejvs.2013.12.018	
127	Occlusive Disease 	Carotid	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease etiology and risk factors	Carotid atherosclerotic plaque	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Geoghegan P.H.	10.1007/s00348-013-1528-0	
128	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease mechanism (exp/theor)	Prosthesis effectiveness evaluation	Transcatheter aortic valve implantation	Not relevant (e.g. in silico)	Supportive	Optimisation	2014	Gessat M.	10.1109/TBME.2013.2273496	
129	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prosthesis effectiveness evaluation	Polymeric aortic valve	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Gharaie S.H.	10.1007/s13239-018-0340-7	
130	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Aortic calcification	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Ghosh R.P.	10.1115/1.4040600	
131	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Diagnosis of diseases	Functional assessment of arrhythmia response to drugs	High (Automated)	Supportive	Under validation	2015	Gilchrist K.H.	10.1016/j.taap.2015.07.024	
132	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Abdominal aortic aneurysm	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Gindre J.	10.1109/TBME.2016.2587362	
133	Cardiovascular Abnormalities including CCD 	NA	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Congenital heart disease	High (Automated)	Predictive	Under development 	2014	Glessner J.T.     	10.1161/CIRCRESAHA.115.304458	
134	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	ex vivo	NA	Disease mechanism (exp/theor)	Treatment strategies evaluation	Vascular genetic reactivity	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Glória S.	10.1016/j.tiv.2018.03.006	
135	Heart Failure 	NA	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	LVAD systems hemodynamic comparison	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Gohean J.R.	10.1097/MAT.0b013e31827db6d4	
136	Myocardia Ischemia	NA	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Coronary plaques	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Gökgöl C.	10.1007/s10439-017-1803-y	
137	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Aortic coarctation 	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Goubergrits L.	10.1007/s10439-014-1116-3	
138	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Coronary artery stenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Govindaraju K.	10.1016/j.atherosclerosis.2014.01.043	
139	Heart Valve Diseases 	Mitral Valve	in vitro with cells	3D culture	Disease therapy development	Prosthesis development	Mitral valve scaffold realisation feasibility	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Granados M.	10.1007/s12265-017-9747-z	
140	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prosthesis effectiveness evaluation	Rotary blood pumps interactions	Not relevant (e.g. in silico)	Supportive	Optimisation	2016	Granegger M.	10.1109/TBME.2015.2489188	
141	Heart Valve Diseases 	Aortic Valve	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Valve insufficiency	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Granegger M.	10.1111/aor.12167	
142	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Repair procedure evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Grbic S.	10.1016/j.media.2016.03.011	
143	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease mechanism (exp/theor)	Treatment strategies evaluation	Hypertension complications	Medium / Low (Lab scale)	Supportive	Under development 	2017	Greaney J.L.	10.1161/HYPERTENSIONAHA.116.08964	
144	Occlusive Disease 	Carotid	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Carotid atherosclerotic plaque	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Guerciotti B.	10.1016/j.jbiomech.2015.11.009	
145	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Chordae tendineae calcification 	Medium / Low (Lab scale)	Predictive	Under validation	2016	Gunning G.M. & Murphy B.P.	10.1016/j.jmbbm.2016.01.009	
146	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Transcatheter aortic valve replacement	Not relevant (e.g. in silico)	Supportive	Under validation	2014	Gunning P.S.	10.1007/s10439-014-1008-6	
147	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Prediction of QT prolongation;  evaluation of cardiac safety liabilities of drug candidates	Medium / Low (Lab scale)	Supportive	Under validation	2013	Guo L.	10.1093/toxsci/kft205	
148	Cardiomyopathies 	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Human myocardium matrix realisation feasibility	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Guyette J.P.	10.1161/CIRCRESAHA.115.306874	
149	Heart Valve Diseases 	Aortic Valve	ex vivo	NA	Diagnosis of disease	Disease etiology and risk factors	Aortic calcification	Medium / Low (Lab scale)	Predictive	Under validation	2016	Hadji F.	10.1161/CIRCULATIONAHA.116.023116	
150	Cardiomyopathies 	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Myocardial Stiffness measurement	Medium / Low (Lab scale)	Supportive	Under development 	2017	Hadjicharalambous M.	10.1007/s10439-016-1721-4	
151	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Fontan connection	High (Automated)	Supportive	Under development 	2014	Haggerty C.M. 	10.1016/j.jtcvs.2013.11.060	
152	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease etiology and risk factors 	Mitral valve remodeling evaluation	Medium / Low (Lab scale)	Predictive	Under validation	2013	Hagler M.A.	10.1093/cvr/cvt083	
153	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Halevi R.	10.1115/1.4040338	
154	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device development	Vascular hemodynamics	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Han X.	10.1088/1758-5090/8/2/025018	
155	Cardiomyopathies 	NA	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors 	Left ventricular thrombosis evaluation	Medium / Low (Lab scale)	Predictive	Under development 	2017	Harfi T.T.	10.1016/j.ijcard.2016.10.079	
156	Aneurysm	Cerebral	ex vivo	NA	Disease therapy development	Treatment strategies evaluation	Thrombus formation	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Haworth K.J.	10.1136/neurintsurg-2013-011076	
157	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease therapy development	Disease mechanism and progression	Effects of arrhythmia on ventricular contraction	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Heikhmakhtiar A.K.	10.3389/fphy.2018.00147	
158	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Device development	Aneurysm endovascular repair	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Hemmler A.	10.1007/s10237-019-01125-5	
159	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Prediction of device effects	Aneurysm endovascular repair	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Hemmler A.	10.1007/s10237-018-1020-0	
160	Cardiomyopathies 	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Septal myectomy	Medium / Low (Lab scale)	Direct	Under development 	2018	Hermsen J.L.	10.1016/j.jtcvs.2017.09.136	
161	Heart Valve Diseases 	Pulmonary Valve	in silico	FEM	Disease mechanism (exp/theor)	Prediction of prosthesis profile	Valve mechanics	Not relevant (e.g. in silico)	Supportive	Standardised 	2015	Heyden S.	10.1016/j.jbiomech.2015.10.043	
162	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Diagnosis of disease	Device development	Tissue and organ replacement therapies	Medium / Low (Lab scale)	Predictive	Under development 	2015	Hinderer S.	10.1002/adhm.201400762	
163	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2016	Hjortnaes J.	10.1016/j.yjmcc.2016.03.004	
164	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Disease therapy development	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Supportive	Under validation	2015	Hjortnaes J.	10.1016/j.atherosclerosis.2015.07.008	
165	Cardiovascular Abnormalities including CCD 	NA	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Congenital heart disease	High (Automated)	Predictive	Under development 	2015	Homsy J.  	10.1126/science.aac9396	
166	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Paravalvular leak	Not relevant (e.g. in silico)	Predictive	Optimisation	2017	Hopf R.	10.1016/j.jbiomech.2016.12.038	
167	Occlusive Disease 	Peripheral vessel	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Vascular stent resistence evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Hsiao H.-M.	10.1016/j.commatsci.2014.01.023	
168	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Treatment strategies evaluation	Inflammation related to platelet and leukocyte	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Huang G.-S.	10.1097/SHK.0000000000000972	
169	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Carotid atherosclerotic plaque	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Huang Y.	10.1016/j.jbiomech.2014.01.030	
170	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Predictive	Under validation	2016	Huk D.J.	10.1161/ATVBAHA.115.306091	
171	Heart Failure 	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Lead position effect on cardiac resynchronisation	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Huntjens P.R.	10.1093/europace/euu231	
172	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Predictive	Under validation	2013	Hutcheson J.D.	10.1161/ATVBAHA.112.300278	
173	Heart Failure 	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Cardiac resynchronisation outcomes prediction	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Hyde E.R.	10.1161/CIRCEP.115.002677	
174	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Iannaccone F.	10.1007/s10439-015-1505-2	
175	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Prediction of device effects	Stenting procedure for severe carotid stenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Iannaccone F.	10.1016/j.jbiomech.2014.01.008	
176	Myocardia Ischemia	NA	in vitro without cells	NA	Diagnosis of disease	Treatment strategies evaluation	Coronary bifurcation lesions	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Ishibashi Y.	10.1002/ccd.25618	
177	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Myocardial infarction repair	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Izadifar M.	10.1089/ten.tec.2017.0346	
178	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Disease mechanism and progression	Assessment of antiarrhythmic potential of drug candidates	Medium / Low (Lab scale)	Unknown	Under development 	2018	Izumi-Nakaseko H.	10.1016/j.jphs.2018.07.011	
179	Aneurysm	Cerebral	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Janiga G.	10.1016/j.jbiomech.2012.08.047	
180	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Coronary artery disease	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Jaquet C.	10.1109/TBME.2018.2865667	
181	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Device effectiveness evaluation	Heart failure	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Jung B.	10.1016/j.jtcvs.2015.02.048	
182	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Mitral valve regurgitation	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Kamakoti R.	10.1038/s41598-019-52342-y	
183	Heart Valve Diseases 	Pulmonary Valve	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Prosthesis development	Narrowed/leaking pulmonary valve	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Kan C.-D.	10.1109/ACCESS.2018.2815599	
184	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Prediction of prosthesis profile	TMVR outcome prediction	Medium / Low (Lab scale)	Predictive	Optimisation	2018	Karády J.	10.1016/j.jcct.2017.12.007	
185	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Gene correction effectiveness on R14del mutation	Medium / Low (Lab scale)	Supportive	Under development 	2015	Karakikes I.	10.1038/ncomms7955	
186	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease mechanism (exp/theor)	Disease effects on specific organs	Understanding of ventricular fibrillation risk induced by drugs	Not relevant (e.g. in silico)	Predictive	Optimisation	2016	Karathanos T.V.	10.1113/JP271739	
187	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Optogenetic mechanisms to restore normal duration of cardiac action potential	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Karathanos T.V.	10.1093/europace/euu250	
188	Heart Failure 	NA	in vitro without cells	NA	Disease therapy development	Device development	LVAD Cannula effect	Not relevant (e.g. in silico)	Direct	Under development 	2017	Karimov J.H.	10.1016/j.healun.2016.09.004	
189	Heart Failure 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Electromechanical model of failing heart	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Kayvanpour E.    	10.1371/journal.pone.0134869	
190	Myocardia Ischemia	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Diagnosis of diseases	Acute myocardial infarction	High (Automated)	Direct	Optimisation	2017	Kemper D.W.	10.1016/j.clinbiochem.2016.11.011	
191	Heart Failure 	NA	in silico	FEM	Disease mechanism (exp/theor)	Prediction of post-intervention outcomes	SVR evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Khalafvand S.S.	10.1002/cnm.2643	
192	Aneurysm	Cerebral	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Aneurysm rupture	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Khan M.O.	10.1002/cnm.2836	
193	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Atrial fibrillation suppression	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Kharche S.R.	10.1093/europace/euu084	
194	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Arrhythmogenic right ventricular dysplasia iPSC study	Medium / Low (Lab scale)	Supportive	Under development 	2013	Kim C.	10.1038/nature11799	
195	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Coronary stent therapy	Medium / Low (Lab scale)	Predictive	Optimisation	2014	Kim K.-H.	10.1016/j.jcin.2013.05.024	
196	Aneurysm	Aorta	in vitro with cells	2D culture 	Diagnosis of disease	Diagnosis of diseases	Aortic dissection	Medium / Low (Lab scale)	Predictive	Under validation	2017	Kimura N.	10.1093/ejcts/ezx095	
197	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Bicuspid aortic valve	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Kimura N.	10.1016/j.jtcvs.2016.12.033	
198	Cardiovascular Abnormalities including CCD 	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Cardiac malformations	Not relevant (e.g. in silico)	Supportive	Under validation	2016	Kiraly L.	10.1093/icvts/ivv320	
199	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Prosthesis effectiveness evaluation	Annuloplasty	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Kong F.	10.1371/journal.pone.0198331	
200	Heart Valve Diseases 	Tricuspid Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	TV dynamic characterisation	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Kong F.	10.1007/s10439-018-2024-8	
201	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Coronary artery stenosis 	Medium / Low (Lab scale)	Predictive	Under development 	2014	Kousera C.A.	10.1109/TBME.2014.2310954	
202	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease mechanism (exp/theor)	Prediction of device effects	Exercise in Fontan patients	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Kung E.	10.1007/s10439-014-1131-4	
203	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Planning of thoracic surgery	Medium / Low (Lab scale)	Supportive	Under development 	2015	Kurenov S.N.	10.1016/j.jtcvs.2014.12.059	
204	Myocardia Ischemia	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease etiology and risk factors	Cell regrowth in coronary diseases	Medium / Low (Lab scale)	Supportive	Under validation	2018	Lai Z.	10.1016/j.biopha.2017.10.062	
205	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Mitral valve regurgitation	Not relevant (e.g. in silico)	Supportive	Optimisation	2018	Laing J.	10.1117/1.JMI.5.2.021222	
206	Heart Failure 	NA	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Lead position effect on cardiac resynchronisation	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Lee A.W.C.	10.1111/jce.13134	
207	Aneurysm	Cerebral	in vitro without cells	NA	Disease therapy development	Device development	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Lee C.-Y	10.1007/s00234-014-1378-3	
208	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Cardiac perfusion	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Lee J.	10.1007/s10237-016-0782-5	
209	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease mechanism (exp/theor)	Treatment strategies evaluation	Cardiac growth and remodeling	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Lee L.C.	10.1007/s10237-015-0723-8	
210	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease therapy development	Disease mechanism and progression	Prediction of arrhythmia risk induced by drugs	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Lee W.	10.1016/j.pbiomolbio.2015.12.005	
211	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Dilated Cardiomyopathy iPSC study	Medium / Low (Lab scale)	Supportive	Under development 	2017	Lee Y.-K.	10.1161/JAHA.117.005677	
212	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	TMVR simulator	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Leopaldi A.M.	10.1016/j.jtcvs.2017.09.011	
213	Occlusive Disease 	Carotid	in vitro without cells	NA	Disease mechanism (exp/theor)	Device effectiveness evaluation	Carotid restenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Lettau M.	10.1016/j.neurad.2013.10.003	
214	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Left atrial appendage occlusion	Medium / Low (Lab scale)	Supportive	Optimisation	2017	Li H.	10.1016/j.ijcard.2017.01.031	
215	Cardiovascular Surgical and interventional Procedures	Reperfusion	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Myocardial ischemia/reperfusion injury	Medium / Low (Lab scale)	Predictive	Optimisation	2017	Li Q.	10.1159/000470806	
216	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease mechanism (exp/theor)	Device development	Coagulation abnormality	Medium / Low (Lab scale)	Supportive	Under development 	2019	Li Y.	10.1186/s12951-019-0458-2	
217	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Fontan circulation	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Liang F.	10.1152/ajpheart.00245.2014	
218	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Study of cardiac drug-related cardiotoxicity response	Medium / Low (Lab scale)	Supportive	Under development 	2013	Liang P.	10.1161/CIRCULATIONAHA.113.001883	
219	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Stroke	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Lich K.H.	10.1161/STROKEAHA.114.004694	
220	Cardiomyopathies 	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Design of Cardiac microphysiological devices	Medium / Low (Lab scale)	Supportive	Under development 	2017	Lind J.U.	10.1038/nmat4782	
221	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Mitral Valve Intervention Repair	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Little S.H.	10.1016/j.jcin.2016.02.027	
222	Cardiovascular Surgical and interventional Procedures	Reperfusion	ex vivo	NA	Disease mechanism (exp/theor)	Disease etiology and risk factors	Myocardial ischemia/reperfusion injury	Medium / Low (Lab scale)	Predictive	Under development 	2019	Liu H.	10.1111/jcmm.14163	
223	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Delayed afterdepolarisations effects on arrhythmia trigger	Not relevant (e.g. in silico)	Unknown	Under development 	2015	Liu K.-S.	10.1016/j.hrthm.2015.06.019	
224	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Cerebral aneurysm	Medium / Low (Lab scale)	Supportive	Optimisation	2017	Liu M.B.	10.1038/srep44301	
225	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Aortic arch replacement	Not relevant (e.g. in silico)	Supportive	Optimisation	2016	Liu Y.	10.1007/s10439-015-1345-0	
226	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Drugs effects on atrial electrophysiology	Not relevant (e.g. in silico)	Unknown	Under development 	2014	Loewe A.	10.1093/europace/euu230	
227	Myocardia Ischemia	NA	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Diagnosis of diseases	Early myocardial ischemia	Medium / Low (Lab scale)	Supportive	Under validation	2015	Loewe A.	10.1155/2015/530352	
228	Heart Failure 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Intraventricular pressure exstimation	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Londono-Hoyos F.J.	10.1007/s11517-017-1704-0	
229	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Mitral valve regurgitation	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Loor G. 	10.1016/j.athoracsur.2015.12.070	
230	Heart Failure 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Electromechanical model of cardiac resynchronisation  	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Lumens J.	10.1161/CIRCIMAGING.115.003744	
231	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Arrhythmogenic right ventricular cardiomyopathy iPSC study	Medium / Low (Lab scale)	Supportive	Under validation	2013	Ma D.	10.1093/eurheartj/ehs226	
232	Aneurysm	Cerebral	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Ma D.	10.3174/ajnr.A3933	
233	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	MV FSI characterisation	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Ma X.	10.1016/j.compfluid.2012.10.025	
234	Heart Valve Diseases 	Mitral Valve	in vitro with cells	3D culture	Disease mechanism (exp/theor)	Disease mechanism and progression	Strain regulation on mitral valve regurgitation	Not relevant (e.g. in silico)	Predictive	Under validation	2019	Maeda K.	10.1016/j.athoracsur.2018.08.084	
235	Heart Failure 	NA	in silico	others (including analytical models, cell population dynamics etc.)	Diagnosis of disease	Treatment strategies evaluation	LVAD fluidodynamic evaluation	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Mahmood M.N.	10.5301/ijao.5000366	
236	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease mechanism and progression	Aortic calcification	Medium / Low (Lab scale)	Predictive	Under validation	2014	Mahmut A.	10.1016/j.jacc.2013.05.105	
237	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aortic calcification	Not relevant (e.g. in silico)	Direct	Standardised 	2014	Maleki H.	10.1007/s11517-013-1113-y	
238	Cardiomyopathies 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	DCM Fluidynamic characterisation	Medium / Low (Lab scale)	Supportive	Under development 	2013	Mangual J.O.	10.1016/j.jbiomech.2013.04.012	
239	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Paravalvular leak	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Mao W.	10.1115/1.4040457	
240	Occlusive Disease 	Veins	in silico	others (including analytical models, cell population dynamics etc.)	Diagnosis of disease	Disease etiology and risk factors	Venous system abnormalities in central nervous system	High (Automated)	Predictive	Under validation	2015	Marcotti S.	10.1186/s12883-015-0352-y	
241	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Detection of trigger mechanism in familial atrial fibrillation	Medium / Low (Lab scale)	Unknown	Under development 	2017	Marczenke M.	10.3389/fphys.2017.00469	
242	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Complex aortic diseases	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Marone E.M.	10.23736/S0021-9509.18.10324-7	
243	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Single ventricle physiology and coronary aneurysms caused by Kawasaki disease	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Marsden A.L.	10.1063/1.4825031	
244	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Prosthesis effectiveness evaluation	Transcatheter aortic valve implantation	Not relevant (e.g. in silico)	Supportive	Optimisation	2017	Martin C.	10.1007/s10439-016-1738-8	
245	Aneurysm	Cerebral	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Intra-stent thrombi	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Martínez-Galdámez M.	10.1177/1591019918808466	
246	Aneurysm	Cerebral	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Aneurysm clipping repair	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Mashiko T.	10.1016/j.jsurg.2016.12.010	
247	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Prosthesis development	Aortic calcification	Not relevant (e.g. in silico)	Direct	Under validation	2014	Masoumi N.	10.1016/j.biomaterials.2014.04.039	
248	Cardiomyopathies 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	ARMC electromechanical characterisation 	Medium / Low (Lab scale)	Supportive	Under development 	2016	Mast T.P.	10.1016/j.jacc.2016.08.061	
249	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Hypertrophic cardiomyopathy troponin study	Medium / Low (Lab scale)	Supportive	Under development 	2017	Matyushenko A.M.	10.1021/acs.biochem.6b00994	
250	Myocardia Ischemia	NA	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease mechanism and progression	Myocardial ischemia/reperfusion injury	Medium / Low (Lab scale)	Supportive	Under validation	2017	McDougal A.D.	10.1074/jbc.M116.751826	
251	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease mechanism and progression	Determination of mechanisms by which atrial fibrosis contributes to atrial fibrillation	Not relevant (e.g. in silico)	Predictive	Under development 	2013	McDowell K.S.	10.1016/j.bpj.2013.05.025	
252	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Cerebral aneurysm	Not relevant (e.g. in silico)	Predictive	Under development 	2014	McGah P.M.	10.1007/s10439-013-0930-3	
253	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Shortening of  QT duration	Medium / Low (Lab scale)	Supportive	Under validation	2018	Mehta A.	10.1093/eurheartj/ehx394	
254	Occlusive Disease 	Veins	in vitro without cells	NA	Diagnosis of disease	Treatment strategies evaluation	Vein of Galen malformation 	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Meila D.	10.1136/neurintsurg-2016-012568	
255	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Understanding of the molecular basis of antiarrhythmics	Medium / Low (Lab scale)	Predictive	Under development 	2015	Melgari D.	10.1016/j.yjmcc.2015.06.021	
256	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Diagnosis of diseases	Heart Failure	Not relevant (e.g. in silico)	Supportive	Under validation	2015	Menasché P.	10.1093/eurheartj/ehv189	
257	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Aortic coarctation	Not relevant (e.g. in silico)	Predictive	Under validation	2017	Mirzaee H.	10.1002/jmri.25366	
258	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Prediction of post-intervention outcomes	Coronary stent hemocompatibility 	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Mohan C.C.	10.1016/j.actbio.2013.08.023	
259	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Aneurysm rupture	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Mohd Adib M.A.H.	10.1007/s11517-017-1617-y	
260	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	FEM	Diagnosis of disease	Surgical and/or interventional planning	Inter atrial wall intervention	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Morais P.	10.1002/mp.12559	
261	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Identification of therapeutic strategies for  arrhythmia-provoking situations	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Moreno J.D.	10.1161/CIRCRESAHA.113.301971	
262	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Neochord effectiveness evaluation	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Morgan A.E.	10.1016/j.jss.2016.07.011	
263	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Stent procedure for coronary bifurcation	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Morlacchi S. 	10.1016/j.medengphy.2013.01.007	
264	Myocardia Ischemia	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Coronary restenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Morris P.D.	10.1002/ccd.27640	
265	Occlusive Disease 	Peripheral vessel	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Stent fracture in paripheral artery disease  	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Morrison J.W.	10.1583/13-4530MR.1	
266	Heart Valve Diseases 	Tricuspid Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	TV surgical evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Muraru D.	10.1093/ehjci/jew215	
267	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease mechanism (exp/theor)	Prediction of device effects	Left coronary circulation	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Mynard J.P.	10.1152/ajpheart.00603.2013	
268	Aneurysm	Cerebral	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Aneurysm rupture	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Nam S.-W.	10.1016/j.jbiomech.2014.11.018	
269	Heart Failure 	NA	in silico	FEM	Disease therapy development	Prediction of device effects	LVAD fluidodynamic evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Nammakie E.	10.1007/s11517-016-1523-8	
270	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Severe aortic stenosis 	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Nappi F.	10.1155/2018/1346308	
271	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Thoracic aorta aneurysm	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Nauta F.J.H.	10.1136/bmjopen-2016-012270	
272	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Aortic thrombosis	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Nauta F.J.H.	10.1016/j.athoracsur.2016.09.067	
273	Occlusive Disease 	Carotid	in silico	FEM	Disease therapy development	Prediction of device effects	Cannulation effects on cerebral perfusion	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Neidlin M.	10.1007/s10439-014-1064-y	
274	Aneurysm	Aorta	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Abdominal aortic aneurysm	Medium / Low (Lab scale)	Predictive	Under validation	2016	Niestrawska J.A.	10.1098/rsif.2016.0620	
275	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Coronary arteries plaque	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Nikolić D.	10.1016/j.cmpb.2014.07.012	
276	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Coronary disease	High (Automated)	Direct	Optimisation	2014	Nørgaard B.L.	10.1016/j.jacc.2013.11.043	
277	Aneurysm	Aorta	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aneurysm hemodynamics	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Numata S.	10.1093/ejcts/ezv459	
278	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Hypertrophic cardiomyopathy iPSC study	Medium / Low (Lab scale)	Supportive	Under development 	2016	Ojala M.	10.1155/2016/1684792	
279	Myocardia Ischemia	NA	in vitro with cells	3D culture	Diagnosis of disease	Prediction of post-intervention outcomes	Scaffold implant complications	Not relevant (e.g. in silico)	Predictive	Under validation	2017	Ortega-Paz L. 	10.4244/EIJ-D-16-00974	
280	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Disease mechanism and progression	Understanding  of the behavior of long QT forms which can induce arrhythmias	Medium / Low (Lab scale)	Unknown	Under development 	2018	Paci M.	10.3390/ijms19113583	
281	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Neochord effectiveness evaluation	Medium / Low (Lab scale)	Predictive	Under development 	2013	Padala M.	10.1016/j.athoracsur.2012.09.055	
282	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Understanding of the molecular basis of inherited arrhythmia	Medium / Low (Lab scale)	Predictive	Optimisation	2018	Pahlavan S.	10.1096/fj.201700494RR	
283	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Diagnosis of disease	Surgical and/or interventional planning	Aortic regurgitation	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Palau-Caballero G.	10.1016/j.echo.2016.07.015	
284	Heart Valve Diseases 	Pulmonary Valve	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease mechanism and progression	Right ventricular failure	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Palau-Caballero G.	10.1152/ajpheart.00596.2016	
285	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Atrioventricular valve regurgitation	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Pant S.	10.1109/TBME.2018.2797999	
286	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Prediction of post-intervention outcomes	Annuloplasty	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Pantoja J.L.	10.1016/j.athoracsur.2016.07.021	
287	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Coronary lesions	High (Automated)	Supportive	Optimisation	2014	Papafaklis M.I.	10.4244/EIJY14M07_01	
288	Aneurysm	Coronary	in vitro without cells	NA	Diagnosis of disease	Treatment strategies evaluation	Coronary artery anomalies	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Parimi M.	10.1007/s00246-017-1799-y	
289	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Marfan syndrome	Medium / Low (Lab scale)	Supportive	Under development 	2017	Park J.W.	10.7150/ijbs.19517	
290	Aneurysm	Aorta	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Thoracic endovascular aortic repair	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Pasta S.	10.1177/1526602815611888	
291	Heart Failure 	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Extracellular ventricular model	Not relevant (e.g. in silico)	Supportive	Under validation	2015	Patel N.M.	10.1097/MAT.0000000000000158	
292	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Treatment strategies evaluation	Atherosclerotic lesion formation	Medium / Low (Lab scale)	Predictive	Under validation	2014	Patibandla P.K.	10.1021/ac503294p	
293	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Ablation of Atrial Fibrillation	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Pérez J.J.	10.1111/jce.12630	
294	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Perrin D.	10.1016/j.jbiomech.2015.04.031	
295	Occlusive Disease 	Veins	in silico	FEM	Disease therapy development	Prediction of device effects	Failure mechanisms of Peripheral intravenous catheters	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Piper R.	10.1038/s41598-018-21617-1	
296	Heart Failure 	NA	in silico	FEM	Diagnosis of disease	Treatment strategies evaluation	Cardiac resynchronisation outcomes prediction	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Pluijmert M.	10.15420/aer.2015.4.1.62	
297	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Thrombus formation	Medium / Low (Lab scale)	Supportive	Under validation	2015	Polanczyk A.	10.1016/j.jbiomech.2014.12.033	
298	Heart Valve Diseases 	Tricuspid Valve	in silico	FEM	Disease therapy development	Prosthesis development	TV prosthesis design	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Pott D.	10.1111/aor.12605	
299	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Gene therapy of hypertrophic cardiomyopathy effectiveness evaluation	Medium / Low (Lab scale)	Supportive	Under development 	2017	Prondzynski M.	10.1016/j.omtn.2017.05.008	
300	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Myocardial infarction repair	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Puig-Sanvicens V.A.C.	10.1016/j.diff.2015.11.002	
301	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Detection of drug-induced arrhythmia and  assessment of preclinical cardiac toxicity	Medium / Low (Lab scale)	Supportive	Under validation	2015	Qu Y.	10.1093/toxsci/kfv128	
302	Aneurysm	Aorta	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Marfan syndrome	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Querzoli G.	10.1016/j.jbiomech.2014.06.025	
303	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	MV fluidynamics characterisation	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Rabbah J.-P.	10.1007/s10439-012-0651-z	
304	Occlusive Disease 	Carotid	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Carotid atherosclerotic plaque	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Ramnarine K.V.	10.1016/j.ultrasmedbio.2013.09.014	
305	Heart Failure 	NA	in vitro with cells	2D culture 	Diagnosis of disease	Disease etiology and risk factors	Platelet proteome modification in heart failure patients	Medium / Low (Lab scale)	Predictive	Under development 	2016	Raphael R.	10.1186/s12967-016-0774-3	
306	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease mechanism (exp/theor)	Treatment strategies evaluation	Understanding of the mechanisms for atrial fibrillation termination	Not relevant (e.g. in silico)	Predictive	Under validation	2015	Rappel W.-J.	10.1161/CIRCEP.115.002956	
307	Heart Valve Diseases 	Pulmonary Valve	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Prosthesis development	Congenital pulmonary valve malformation	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Rasmussen R.	10.1186/s13019-019-0830-1	
308	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Annuloplasty	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Rausch M.K.	10.1002/cnm.2788	
309	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Myocardial infarction	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Ravichandran R.	10.1002/mabi.201200391	
310	Occlusive Disease 	Veins	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Surgical procedure for uperior sinus venosus atrial septal defect  and partial anomalous pulmonary venous drainage	Not relevant (e.g. in silico)	Predictive	Under development 	2018	Riahi M.	10.4244/EIJ-D-18-00304	
311	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	MV kinetics characterisation	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Rim Y.	10.1016/j.jbiomech.2013.01.014	
312	Heart Valve Diseases 	Pulmonary Valve	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease etiology and risk factors	Tissue remodeling of native heart valves	Not relevant (e.g. in silico)	Supportive	Optimisation	2018	Ristori T.	10.1016/j.actbio.2018.08.040	
313	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Diagnosis of disease	Disease mechanism and progression	Identification of atrial regions responsible for AF perpetuation	Not relevant (e.g. in silico)	Unknown	Under validation	2014	Rodrigo M.	10.1016/j.hrthm.2014.05.013	
314	Aneurysm	Cerebral	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Aneurysm rupture	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Roloff C.	10.1016/j.ijheatfluidflow.2013.06.006	
315	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Transcatheter aortic valve replacement	Medium / Low (Lab scale)	Direct	Under development 	2019	Rotman O.M.	10.1007/s10439-018-02119-7	
316	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Device development	Aneurysm stent repair	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Roy D.	10.1002/cnm.2769	
317	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device development	Graft failure in Peripheral Vascular Disease and Coronary Artery Disease	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Ruiz-Soler A.	10.1038/s41598-017-01930-x	
318	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Disease etiology and risk factors	Prediction of arrhythmia risk induced by drugs	Not relevant (e.g. in silico)	Predictive	Optimisation	2018	Sahli Costabal F.	10.1002/cnm.2964	
319	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease mechanism (exp/theor)	Treatment strategies evaluation	Stenosis of right coronary artery	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Sakellarios A.I.	10.1152/ajpheart.00539.2012	
320	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease mechanism and progression	Aortic calcification	Medium / Low (Lab scale)	Predictive	Under validation	2018	Schlotter F.   	10.1161/CIRCULATIONAHA.117.032291	
321	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Cardiac surgery and interventional planning	Medium / Low (Lab scale)	Supportive	Under development 	2014	Schmauss D. 	10.1093/ejcts/ezu310	
322	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Intracranial aneurysms 	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Schneiders J.J.	10.3174/ajnr.A3179	
323	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Calcium displacement	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Schultz C.	10.4244/EIJV11I9A212	
324	Aneurysm	Aorta	in vitro without cells	NA	Disease therapy development	Prediction of device effects	Aneurysm endovascular repair	Medium / Low (Lab scale)	Supportive	Under validation	2018	Schuurmann R.C.L.	10.1177/1526602818764413	
325	Cardiovascular Surgical and interventional Procedures	Reperfusion	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Myocardial ischemia/reperfusion injury	Medium / Low (Lab scale)	Predictive	Optimisation	2019	Sebastião M.J.	10.1186/s13287-019-1174-4	
326	Cardiovascular Abnormalities including CCD 	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Aortic coarctation	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Segers P.	10.1097/HJH.0000000000000449	
327	Myocardia Ischemia	NA	in vitro without cells	NA	Disease therapy development	Prediction of post-intervention outcomes	Coronary stent therapy	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Seidlitz A.	10.1016/j.ejpb.2015.04.016	
328	Heart Failure 	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	LVAD fluidodynamic evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Sénage T.	10.1097/MAT.0000000000000045	
329	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Coronary artery aneurysms	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Sengupta D.	10.1007/s10237-014-0570-z	
330	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Diagnosis of disease	Prediction of post-intervention outcomes	Abdominal aortic aneurysm	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Shang E.K.	10.1016/j.jvs.2013.08.032	
331	Cardiovascular Abnormalities including CCD 	NA	in vitro without cells	NA	Disease mechanism (exp/theor)	Diagnosis of diseases	Congenital heart disease	High (Automated)	Predictive	Under development 	2018	Shanshen E. 	10.1007/s00246-017-1741-3	 
332	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve myofibroblastic activation evaluation	Medium / Low (Lab scale)	Predictive	Under validation	2015	Shapero K.	10.1016/j.yjmcc.2015.01.006	
333	Heart Failure 	NA	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Antiplatelet drugs efficacy with LVAD	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Sheriff J.	10.1007/s11239-013-0997-6	
334	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Risk of stroke	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Sia S.F.	10.1016/j.powtec.2018.07.091	
335	Heart Failure 	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Lead position effect on cardiac resynchronisation	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Siciliano M.	10.1093/europace/euw331	
336	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve regurgitation	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Siefert A.W.	10.1016/j.athoracsur.2012.11.039	
337	Heart Valve Diseases 	Aortic Valve	in vitro without cells	NA	Disease therapy development	Disease mechanism and progression	Aortic valve replacement	Not relevant (e.g. in silico)	Supportive	Under validation	2015	Sierad L.N.	10.1089/ten.tec.2015.0170	
338	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Aortic valve dynamics	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Sigüenza J.	10.1002/cnm.2945	
339	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Aortic valve failure	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Simonato M. 	10.4244/EIJV12I7A149	
340	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Marfan aorta	Not relevant (e.g. in silico)	Predictive	Optimisation	2016	Singh S.D.	10.1016/j.jbiomech.2015.11.040	
341	Heart Valve Diseases 	Tricuspid Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	TV dynamic characterisation	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Singh-Gryzbon S.	10.1007/s10439-019-02243-y	
342	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Understanding of the refractoriness role to prevent arrhythmias	Medium / Low (Lab scale)	Predictive	Under development 	2016	Skibsbye L.	10.1016/j.yjmcc.2016.10.009	
343	Heart Failure 	NA	in silico	FEM	Disease therapy development	Device development	Total artificial heart design	Not relevant (e.g. in silico)	Direct	Under validation	2013	Slepian M.J.	10.1016/j.jbiomech.2012.11.032	
344	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Disease etiology and risk factors	Understanding of the proarrhythmic potential of drugs	Medium / Low (Lab scale)	Unknown	Under development 	2019	Slotvitsky M.	10.1093/toxsci/kfy274	
345	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device development	Atrial septal occluder	Medium / Low (Lab scale)	Supportive	Optimisation	2017	So K.C.-Y.	10.1016/j.jcin.2017.02.045	
346	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Prosthesis effectiveness evaluation	Aortic valve dynamics	Not relevant (e.g. in silico)	Supportive	Optimisation	2018	Sodhani D.	10.1016/j.jbiomech.2018.07.018	
347	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease etiology and risk factors 	Osteoprotegerin on mitral valve prolapse	Medium / Low (Lab scale)	Predictive	Under validation	2016	Songia P.	10.1016/j.yjmcc.2016.06.061	
348	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Disease etiology and risk factors	Functionally targeted interventions for the treatment of arrhythmia	Medium / Low (Lab scale)	Predictive	Optimisation	2014	Spencer C.I.	10.1016/j.stemcr.2014.06.003	
349	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Device development	Antithrombotic graft	Medium / Low (Lab scale)	Supportive	Under development 	2018	Stahl A.M.	10.1002/adhm.201800222	
350	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	ex vivo	NA	Disease mechanism (exp/theor)	Treatment strategies evaluation	Induced vasorelaxation	Medium / Low (Lab scale)	Supportive	Optimisation	2014	Stanley C.P.	10.1016/j.phrs.2014.02.001	
351	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Development of screening assays for testing individual drug reactions	Medium / Low (Lab scale)	Predictive	Optimisation	2017	Stillitano F.    	10.7554/eLife.19406	
352	Heart Valve Diseases 	Tricuspid Valve	in vitro without cells	NA	Disease therapy development	Prediction of post-intervention outcomes	TV repair treatment evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Stock S.	10.1016/j.jtcvs.2017.10.068	
353	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Coronary obstruction after TAVI valve-in-valve	Medium / Low (Lab scale)	Supportive	Under validation	2017	Stock S.	10.1016/j.jtcvs.2016.09.086	
354	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Dilated Cardiomyopathy iPSC study	Medium / Low (Lab scale)	Supportive	Under development 	2017	Streckfuss-Bömeke K.	10.1016/j.yjmcc.2017.09.008	
355	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Mitral valve regurgitation	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Sturla F.	10.1016/j.jbiomech.2016.11.013	
356	Cardiomyopathies 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	DCM Fluidynamic characterisation	Medium / Low (Lab scale)	Predictive	Under development 	2014	Su B.	10.1109/IECBES.2014.7047502	
357	Heart Failure 	NA	in vitro without cells	NA	Disease therapy development	Device development	LVAD fluidodynamic evaluation	Not relevant (e.g. in silico)	Direct	Under development 	2015	Sunagawa G.	10.1016/j.jtcvs.2015.04.015	
358	Occlusive Disease 	Peripheral vessel	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	Underdeployment in stent apposition 	Medium / Low (Lab scale)	Supportive	Under development 	2014	Svendsen M.C.	10.1016/j.jvs.2013.06.095	
359	Heart Valve Diseases 	Pulmonary Valve	in vitro with cells	3D culture	Disease therapy development	Prosthesis development	Regurgitation	Medium / Low (Lab scale)	Supportive	Under validation	2013	Syedain Z.H.	10.1089/ten.tea.2012.0365	
360	Heart Valve Diseases 	Aortic Valve	ex vivo	NA	Disease therapy development	Prosthesis development	Aortic valve regurgitation	Not relevant (e.g. in silico)	Direct	Under validation	2015	Tam H.	10.1016/j.biomaterials.2015.07.011	
361	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	Abdominal aortic aneurysm	Medium / Low (Lab scale)	Supportive	Optimisation	2013	Tam M.D.B.S.	10.1583/13-4450MR.1	
362	Cardiomyopathies 	NA	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease mechanism and progression	DCM Fluidynamic characterisation	Medium / Low (Lab scale)	Supportive	Under development 	2018	Tang C.	10.1111/echo.13732	
363	Heart Valve Diseases 	Pulmonary Valve	in silico	FEM	Disease mechanism (exp/theor)	Prediction of prosthesis profile	Hemodynamics in the total cavopulmonary connection	Medium / Low (Lab scale)	Supportive	Optimisation	2013	Tang E.	10.1016/j.jbiomech.2012.11.003	
364	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	General disease effects on the body	Aortic valve dynamics	Not relevant (e.g. in silico)	Direct	Standardised 	2018	Tango A.M.	10.1007/s13239-018-00391-1	
365	Aneurysm	Aorta	ex vivo	NA	Disease mechanism (exp/theor)	Diagnosis of diseases	Abdominal aortic aneurysm	Medium / Low (Lab scale)	Predictive	Standardised 	2015	Tanios F.	10.1016/j.ejvs.2015.03.021	
366	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Arrhythmogenic right ventricular cardiomyopathy iPSC study	Medium / Low (Lab scale)	Supportive	Under development 	2017	Te Riele A.S.J.M.	10.1093/cvr/cvw234	
367	Occlusive Disease 	Carotid	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Atherosclerotic plaque	Medium / Low (Lab scale)	Supportive	Under development 	2014	Teng Z.	10.1016/j.actbio.2014.09.001	
368	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Treatment strategies evaluation	Development of patient-specific clinical regimens	Medium / Low (Lab scale)	Predictive	Optimisation	2013	Terrenoire C.	10.1085/jgp.201210899	
369	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Sinus venosus atrial septal defect and partial anomalous pulmonary venous return of the right upper pulmonary vein	Medium / Low (Lab scale)	Supportive	Optimisation	2018	Thakkar A.N.	10.1002/ccd.27645	
370	Heart Valve Diseases 	Mitral Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease etiology and risk factors 	Mitral valve remodeling evaluation	Medium / Low (Lab scale)	Predictive	Under validation	2015	Thalji N.M.	10.1161/CIRCGENETICS.114.000921	
371	Heart Valve Diseases 	Tricuspid Valve	in vitro without cells	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	TV microstructure characterisation	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Thomas V.S.	10.1016/j.actbio.2019.05.074	
372	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Coronary disease	Not relevant (e.g. in silico)	Supportive	Under development 	2014	Timmins L.H.	10.1007/s10439-014-1155-9	
373	Heart Failure 	NA	in vitro without cells	NA	Diagnosis of disease	Disease mechanism and progression	Vortex-ring mixing evaluation	Not relevant (e.g. in silico)	Predictive	Under validation	2016	Töger J.	10.1002/jmri.25111	
374	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	MV FSI characterisation	Medium / Low (Lab scale)	Supportive	Under development 	2016	Toma M.	10.1007/s10439-015-1385-5	
375	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Diagnosis of disease	Diagnosis of diseases	Influence of sarcoplasmic reticulum (SR) calcium release on arrhythmias	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Tomek J.	10.3389/fphys.2018.01306	
376	Aneurysm	Aorta	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Intraluminal thrombus formation	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Tong J. & Holzapfel G.A.	10.1007/s10439-015-1332-5	
377	Aneurysm	Aorta	in vitro without cells	NA	Diagnosis of disease	Device development	Aneurysm endovascular repair	Medium / Low (Lab scale)	Supportive	Under validation	2017	Torres I.O. & De Luccia N.	10.1016/j.ejvs.2017.05.011	
378	Aneurysm	Aorta	ex vivo	NA	Disease mechanism (exp/theor)	Disease etiology and risk factors	Aneurysm rupture	Medium / Low (Lab scale)	Predictive	Under development 	2018	Trabelsi O.	10.1016/j.jbiomech.2017.11.012	
379	Arrhythmias	Arrhythmias, Cardiac	in silico	others (including analytical models, cell population dynamics etc.)	Disease therapy development	Treatment strategies evaluation	Evaluation of pro-arrhythmic potential of drugs and drug candidates	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Trenor B.	10.4161/chan.24905	
380	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Y graft effects on flow	Medium / Low (Lab scale)	Predictive	Under development 	2016	Trusty P.M.	10.1016/j.jtcvs.2016.03.019	
381	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Direct	Under validation	2014	Tseng H.	10.1016/j.actbio.2013.09.003	
382	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Coronary obstruction	Medium / Low (Lab scale)	Predictive	Optimisation	2014	Tu S.	10.1016/j.jcin.2014.03.004	
383	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Coronary hemodynamics	High (Automated)	Predictive	Standardised 	2016	Tu S.	10.1016/j.jcin.2016.07.013	
384	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Prosthesis effectiveness evaluation	Transcatheter aortic valve implantation	Not relevant (e.g. in silico)	Direct	Standardised 	2013	Tzamtzis S.	10.1016/j.medengphy.2012.04.009	
385	Occlusive Disease 	Carotid	in silico	FEM	Disease therapy development	Disease etiology and risk factors	Carotid restenosis	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Uemiya N.	10.1016/j.jocn.2013.03.042	
386	Heart Failure 	NA	in silico	others (including analytical models, cell population dynamics etc.)	Diagnosis of disease	Disease etiology and risk factors	Prediction of platelet activation in LVAD systems	Not relevant (e.g. in silico)	Predictive	Under development 	2017	Uszko-Lencer N.H.M.K.	10.1016/j.ijcard.2016.11.122	
387	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Leaflet thrombosis	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Vahidkhah K. & Azadani A.N.	10.1016/j.jbiomech.2017.04.020	
388	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Aneurysm rupture	Medium / Low (Lab scale)	Predictive	Under validation	2018	Valen-Sendstad K.	10.1007/s13239-018-00374-2	
389	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Transverse aortic arch hypoplasia	Medium / Low (Lab scale)	Supportive	Optimisation	2015	Valverde I.	10.1002/ccd.25810	
390	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Diagnosis of disease	Surgical and/or interventional planning	Surgical planning for congenital heart defect	Medium / Low (Lab scale)	Supportive	Under development 	2017	Valverde I.    	10.1093/EJCTS/EZX208	
391	Heart Valve Diseases 	Pulmonary Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Fontan circulation correction	Not relevant (e.g. in silico)	Supportive	Under development 	2018	van Bakel T.M.J.	10.1007/s12265-017-9781-x	
392	Cardiovascular Surgical and interventional Procedures	Reperfusion	ex vivo	NA	Disease mechanism (exp/theor)	Disease etiology and risk factors	Myocardial ischemia/reperfusion injury	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Van Den Berg T.N.A.	10.1016/j.ijcard.2016.04.150	
393	Aneurysm	Aorta	in vitro without cells	NA	Disease therapy development	Prediction of device effects	Aneurysm endovascular sealing	Not relevant (e.g. in silico)	Supportive	Under development 	2019	van Schaik T.G.	10.1177/1526602818819494	
394	Myocardia Ischemia	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Coronary microcirculation	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Van't Veer M.	10.4244/EIJV12I6A114	
395	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Arteriovenous hemodialysis fistula	Medium / Low (Lab scale)	Supportive	Optimisation	2014	Varble N.	10.1016/j.jvs.2013.04.055	
396	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Coronary plaques	Medium / Low (Lab scale)	Supportive	Under development 	2014	Vergallo R.	10.1161/CIRCIMAGING.114.001932	
397	Heart Failure 	NA	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Cardiac resynchronisation outcomes prediction	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Villongco C.T.	10.1093/europace/euw356	
398	Heart Valve Diseases 	Tricuspid Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	FTR treatment evaluation	Not relevant (e.g. in silico)	Predictive	Under development 	2016	Vismara R.	10.1016/j.jacc.2016.06.022	
399	Occlusive Disease 	Peripheral vessel	in vitro without cells	NA	Disease therapy development	Disease etiology and risk factors	Tissue accumulation on peripheral artery stents	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Viswanath A.	10.1088/0960-1317/23/2/025010	
400	Heart Valve Diseases 	Mitral Valve	in vitro without cells	NA	Disease therapy development	Surgical and/or interventional planning	TMVR  phantom simulator	Not relevant (e.g. in silico)	Supportive	Optimisation	2017	Vukicevic M.	10.1007/s10439-016-1676-5	
401	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Disease effects on specific organs	Severe aortic stenosis 	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Wald S.	10.1007/s10237-017-0962-y	
402	Heart Failure 	NA	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	Electromechanical model of asynchronous heart	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Walmsley J.	10.1371/journal.pcbi.1004284	
403	Myocardia Ischemia	NA	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Ischemia diagnosis	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Wang D.	10.1016/j.jcp.2013.05.027	
404	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Barth syndrome iPSC study	Medium / Low (Lab scale)	Supportive	Standardised 	2014	Wang G.  	10.1038/nm.3545	
405	Aneurysm	Cerebral	in vitro without cells	NA	Diagnosis of disease	Diagnosis of diseases	Aneurysm rupture	Medium / Low (Lab scale)	Supportive	Under development 	2018	Wang J.-L.	10.1097/MD.0000000000011103	
406	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Aortic root rupture	Not relevant (e.g. in silico)	Supportive	Under development 	2015	Wang Q.	10.1007/s10237-014-0583-7	
407	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease mechanism (exp/theor)	Disease mechanism and progression	MV kinetics characterisation	Medium / Low (Lab scale)	Supportive	Optimisation	2013	Wang Q. & Sun W.	10.1007/s10439-012-0620-6	
408	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease therapy development	Disease mechanism and progression	Aortic valve disease	Not relevant (e.g. in silico)	Direct	Under validation	2017	Wang X.	10.1007/s10439-017-1871-z	
409	Heart Failure 	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Functional cardiac tissue feasibility	Not relevant (e.g. in silico)	Supportive	Under validation	2018	Wang Z.	10.1016/j.actbio.2018.02.007	
410	Aneurysm	Aorta	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Aneurysm growth	High (Automated)	Predictive	Under development 	2017	Wanhainen A.	10.1016/j.atherosclerosis.2016.11.007	
411	Occlusive Disease 	Veins	in vitro without cells	NA	Diagnosis of disease	Diagnosis of diseases	Vein occlusion	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Wartak A.	10.1364/BOE.7.005233	
412	Myocardia Ischemia	NA	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Coronary restenosis	Not relevant (e.g. in silico)	Supportive	Under development 	2019	Wawrzyńska M.	10.1016/j.colsurfb.2018.11.061	
413	Occlusive Disease 	Carotid	ex vivo	NA	Disease mechanism (exp/theor)	Disease etiology and risk factors	Atheroembolic events	Medium / Low (Lab scale)	Supportive	Under development 	2018	Weinkauf C.C.	10.1016/j.jvs.2017.10.088	
414	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Aortic valve regurgitation	Not relevant (e.g. in silico)	Direct	Standardised 	2016	Wendell D.C.	10.1115/1.4033964	
415	Heart Failure 	NA	in silico	FEM	Disease therapy development	Prediction of device effects	CorCap effectiveness characterisation	Not relevant (e.g. in silico)	Predictive	Under development 	2013	Wenk J.F.	10.1016/j.athoracsur.2013.02.032	
416	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro without cells	NA	Diagnosis of disease	Surgical and/or interventional planning	Surgical planning for congenital heart defect	Not relevant (e.g. in silico)	Supportive	Under development 	2018	White S.C.	10.1111/chd.12673	
417	Cardiomyopathies 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Disease mechanism and progression	Hypertrophic cardiomyopathy energetic gene study	Medium / Low (Lab scale)	Supportive	Under development 	2014	Witjas-Paalberends E.R.   	10.1093/cvr/cvu127	
418	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease mechanism (exp/theor)	Device development	Tissue repair and organ replacements	Not relevant (e.g. in silico)	Supportive	Optimisation	2013	Wray L.S.	10.1002/adfm.201202926	
419	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease mechanism and progression	Aortic dilatation	Not relevant (e.g. in silico)	Predictive	Under validation	2016	Wu J.	10.1016/j.jacc.2016.04.027	
420	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in vitro with cells	3D culture	Disease therapy development	Device development	Heart valve-related disease	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Wu S.	10.1016/j.actbio.2017.01.051	
421	Heart Failure 	NA	in silico	FEM	Disease therapy development	Disease etiology and risk factors 	LVAD thrombus evaluation	Not relevant (e.g. in silico)	Direct	Under development 	2016	Wu W.	10.1038/srep38025	
422	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Transcatheter aortic valve replacement	Medium / Low (Lab scale)	Supportive	Under development 	2016	Wu W.-T.	10.1007/s10439-015-1429-x	
423	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Diagnosis of diseases	Aneurysm rupture	Not relevant (e.g. in silico)	Supportive	Under validation	2016	Xiang J.	10.1007/s10439-015-1363-y	
424	Heart Valve Diseases 	Aortic Valve	in vitro with cells	2D culture 	Diagnosis of disease	Disease mechanism and progression	Aortic calcification	Medium / Low (Lab scale)	Predictive	Under validation	2017	Xiao X.	10.1016/j.ijcard.2017.05.037	
425	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease therapy development	Treatment strategies evaluation	Acute myocardial infarction	Medium / Low (Lab scale)	Supportive	Optimisation	2013	Xu D.-Y.	10.1016/j.ijcard.2012.03.167	
426	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Atherosclerotic stenosis of extracranial carotid arteries	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Xu P.	10.1007/s10237-018-1045-4	
427	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Disease therapy development	Prosthesis effectiveness evaluation	Severe aortic stenosis 	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Xuan Y.	10.1016/j.jtcvs.2016.12.016	
428	Cardiovascular Abnormalities including CCD 	NA	in vitro with cells	2D culture 	Disease mechanism (exp/theor)	Diagnosis of diseases	Congenital heart disease	Medium / Low (Lab scale)	Predictive	Under development 	2015	Yamamoto G.L. 	10.1136/jmedgenet-2015-103018	
429	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Disease etiology and risk factors	Prediction of proarrhythmia risk at non-clinical drug development phase	Medium / Low (Lab scale)	Predictive	Optimisation	2018	Yamazaki D.	10.1016/j.jphs.2018.02.005	
430	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	FEM	Disease therapy development	Device effectiveness evaluation	Thrombosis after Y-graft Fontan procedure	Not relevant (e.g. in silico)	Predictive	Under development 	2015	Yang W.	10.1016/j.jtcvs.2014.08.069	
431	Cardiovascular Surgical and interventional Procedures	Cardiac Surgical Procedures	in silico	FEM	Disease therapy development	Prediction of device effects	Alagille syndrome	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Yang W.	10.1111/chd.12556	
432	Aneurysm	Aorta	in vitro with cells	2D culture 	Diagnosis of disease	Diagnosis of diseases	Aortic dissection	Medium / Low (Lab scale)	Predictive	Under development 	2018	Ye J.	10.1016/j.cca.2017.10.033	
433	Cardiovascular Abnormalities including CCD 	NA	in vitro without cells	NA	Disease therapy development	Treatment strategies evaluation	Congenital heart disease	Medium / Low (Lab scale)	Supportive	Under validation	2017	Yoo S.-J. 	10.1016/j.jtcvs.2016.12.054	
434	Heart Valve Diseases 	Aortic Valve	in silico	FEM	Diagnosis of disease	Disease etiology and risk factors	Bicuspid aortic valve	Medium / Low (Lab scale)	Predictive	Under development 	2017	Youssefi P.	10.1016/j.jtcvs.2016.09.040	
435	Heart Valve Diseases 	Aortic Valve	in vitro with cells	3D culture	Disease mechanism (exp/theor)	Disease mechanism and progression	Aortic calcification	Not relevant (e.g. in silico)	Predictive	Under validation	2018	Yu C.	10.1093/cvr/cvx180	
436	Aneurysm	Aorta	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Dissection hemodynamics	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Yu S.C.H	10.1007/s00270-016-1352-z	
437	Aneurysm	Aorta	in silico	FEM	Disease therapy development	Treatment strategies evaluation	Aortic repair	Not relevant (e.g. in silico)	Supportive	Under development 	2017	Yuan D.	10.1038/s41598-017-00644-4	
438	Occlusive Disease 	Carotid	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Disease etiology and risk factors	Risk of stroke	Not relevant (e.g. in silico)	Supportive	Under development 	2013	Yuo T.H.	10.1177/0272989X13491462	
439	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Blood pressure estimation	Not relevant (e.g. in silico)	Supportive	Under development 	2018	Zakrzewski A.M.	10.1109/TBME.2017.2714666	
440	Arrhythmias	Arrhythmias, Cardiac	in silico	FEM	Disease therapy development	Disease mechanism and progression	Understanding of the drug effects on human ventricular activity	Not relevant (e.g. in silico)	Predictive	Under development 	2014	Zemzemi N.	10.1093/europace/euu122	
441	Arrhythmias	Arrhythmias, Cardiac	in vitro with cells	2D culture 	Disease therapy development	Diagnosis of diseases	Prediction of arrhythmias risk	High (Automated)	Predictive	Optimisation	2016	Zeng H.	10.1016/j.vascn.2016.05.009	
442	Aneurysm	Aorta	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Aneurysm growth	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Zhang L.	10.1109/JBHI.2019.2896034	
443	Occlusive Disease 	Carotid	in silico	FEM	Disease mechanism (exp/theor)	Disease etiology and risk factors	Stenosis of vessels	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Zhang Q.	10.1155/2016/8502873	
444	Aneurysm	Cerebral	in silico	FEM	Diagnosis of disease	Disease mechanism and progression	Anterior communicating artery aneurysms	High (Automated)	Predictive	Under development 	2019	Zhang X.	10.1007/s00330-018-5624-7	
445	Heart Valve Diseases 	Mitral Valve	in silico	FEM	Disease therapy development	Surgical and/or interventional planning	Mitral valve regurgitation	Not relevant (e.g. in silico)	Predictive	Under development 	2019	Zhang Y.	10.1371/journal.pone.0223472	
446	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in vitro with cells	3D culture	Disease therapy development	Device development	Perfusion of vascular conduits	Medium / Low (Lab scale)	Supportive	Under development 	2015	Zhang Y.	10.1039/c4bm00234b	
447	Cardiovascular Surgical and interventional Procedures	Vascular Surgical Procedures	in silico	others (including analytical models, cell population dynamics etc.)	Disease mechanism (exp/theor)	Surgical and/or interventional planning	Arrhythmogenesis	Medium / Low (Lab scale)	Supportive	Optimisation	2016	Zhou X.	10.1161/CIRCRESAHA.115.307836	
448	Heart Failure 	NA	in vitro without cells	NA	Disease therapy development	Device effectiveness evaluation	LVAD fluidodynamic evaluation	Not relevant (e.g. in silico)	Supportive	Under development 	2016	Zimpfer D.	10.1093/ejcts/ezw232	
449	Heart Valve Diseases 	Mitral Valve	ex vivo	NA	Disease mechanism (exp/theor)	Disease mechanism and progression	Mitral valve prolaps	Medium / Low (Lab scale)	Supportive	Under development 	2016	Zuo K.	10.1016/j.jmbbm.2016.05.034	